Further, with the advent of medical marijuana, a new group with uncertain psychosis risk could be exposed to cannabis. For these reasons, it would be beneficial if a biological check could be created that predicted the chance for developing cannabis psychosis. This test could possibly be used to advise individuals who abuse cannabis or even to inform marijuana-prescribing decisions by physicians. Recent research has implicated a variation in the gene that codes for a proteins called RAC-alpha serine/threonine-protein kinase in the chance for cannabis psychosis. Nevertheless, independent verification of the findings is crucial for genetic associations with complex genetic traits, like cannabis-related psychosis, because these results are notoriously difficult to reproduce.Furthermore, among kids who received grafts from mismatched related donors or various other donors, those who underwent reduced-strength or myeloablative conditioning were more likely to have normal CD3+ T-cell counts, B-cell chimerism, normal IgA levels, and independence from IVIG therapy than those that underwent immunosuppression or didn’t undergo conditioning . Moreover, full donor chimerism in whole blood and complete or blended chimerism in B cells or myeloid cells were associated with independence from IVIG therapy .